Central regions | Finance, business | Technology & innovation

EU markets to start using new Russian proctology medicine

2 Sep '21
NovaMedica, a Russian pharmaceutical company and portfolio project of the national nanotech company Rusnano, has developed a new drug for colorectal therapy.

The new Russian drug offers in itself a combination of two active ingredients with therapeutic and pain-relieving effects. In its R&D process, NovaMedica is said to have applied technologies enabling such a combination in one product, bringing together substances that were once considered incompatible and exponentially improving their physical-chemical properties as a result.

This past summer the German chemical-pharmaceutical giant Bayer inked an agreement with NovaMedica which gave the Germans an exclusive license for the commercialization of the drug. The German firm obtained the rights to both manufacture the drug and market it.

Bayer is reportedly going to bring the innovative medicine to market under the Reliefipin brand name.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content


Tags: NovaMedica (6) / Bayer (5) / colorectal therapy (0) /

Latest News: Central regions
20 Sep '21 | Transport, logistics | Finance, business
17 Sep '21 | Technology & innovation
17 Sep '21 | Technology & innovation

Feature stories

2 Aug '21
From enhancing the properties of existing materials...
24 May '21
Biophysicists have looked into the way vitally...
1 Apr '21
Search (News archive - 22744)
Marchmont Tech Solutions_ENG
Marchmont News

Latest News

20 Sep '21
One can rent a motor vehicle for a month or more, and...
17 Sep '21
Tomsk scientists and their colleagues have offered a...
15 Sep '21

Most read stories from last week

20 Sep '21
One can rent a motor vehicle for a month or more, and...